I think the saddest thing is that in principle there are non-profit organisations like the Global Health Investment Fund or the Gates Strategic Investment Fund that also invest and have invested in biotechs which could help Cytodyn with a direct investment or a loan but that they have their own research teams and don't accept investment proposals from outsiders.

CYDY would be an ideal fit: huge unmet need in HIV (treatment resistant patients), increasing patient compliance and potentially reducing new infections (mono), potential use for HIV prevention, and potentially paradigm-shifting in cancer...